Thus, to study the potential contribution of mutant Miro1 to PD pathogenesis in vivo, we generated a knock-in mouse model by introducing the corresponding p.R285Q Miro1 mutation using CRISPR/Cas9 technology (Supplementary Fig. 8A). This evidence concerns the gene RHOT1 and Parkinson disease.